Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy

Biomarkers to predict the altering physiological conditions over the period leading toward the ocular disorders are of major importance in therapeutics. Isolation and validation of the biomarkers specific to ocular diseases are a challenging task. Glaucoma is a neurodegenerative disease of the eye w...

Full description

Bibliographic Details
Main Authors: Madhu Nath, Nabanita Halder, Thirumurthy Velpandian
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=3;spage=191;epage=197;aulast=Nath
id doaj-bc867d0b3c51416ab57593167e7a3e1e
record_format Article
spelling doaj-bc867d0b3c51416ab57593167e7a3e1e2020-11-24T23:09:45ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892017-01-0165319119710.4103/ijo.IJO_866_16Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathyMadhu NathNabanita HalderThirumurthy VelpandianBiomarkers to predict the altering physiological conditions over the period leading toward the ocular disorders are of major importance in therapeutics. Isolation and validation of the biomarkers specific to ocular diseases are a challenging task. Glaucoma is a neurodegenerative disease of the eye where the correlation of biomarkers in circulating fluid may be made specific for the eye. However, conditions such as wet age-related macular degeneration (AMD) and proliferative diabetic retinopathy (DR), circulating biomarkers might be having some degree of overlap with other conditions like cancer where a common factor such as angiogenesis is involved. Diabetes, a systemic disorder affecting the target organs such as eye, kidney, heart, and nervous system can be predicted using common circulating biomarkers. However, these markers need to be validated along with various stages of disease progression to enable the possibility of targeted pharmacological interventions apart from good glycemic control alone. This review compiles the attempts made to correlate such circulating biomarkers in the ocular conditions such as glaucoma, AMD, and DR in the search for a surrogate marker for diagnostic and prognostic value. To make biomarkers for the common convenience, genetic markers are excluded from this review.http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=3;spage=191;epage=197;aulast=NathAge-related macular degenerationcirculating biomarkers in glaucomadiabetic retinopathy
collection DOAJ
language English
format Article
sources DOAJ
author Madhu Nath
Nabanita Halder
Thirumurthy Velpandian
spellingShingle Madhu Nath
Nabanita Halder
Thirumurthy Velpandian
Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
Indian Journal of Ophthalmology
Age-related macular degeneration
circulating biomarkers in glaucoma
diabetic retinopathy
author_facet Madhu Nath
Nabanita Halder
Thirumurthy Velpandian
author_sort Madhu Nath
title Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
title_short Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
title_full Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
title_fullStr Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
title_full_unstemmed Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
title_sort circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Ophthalmology
issn 0301-4738
1998-3689
publishDate 2017-01-01
description Biomarkers to predict the altering physiological conditions over the period leading toward the ocular disorders are of major importance in therapeutics. Isolation and validation of the biomarkers specific to ocular diseases are a challenging task. Glaucoma is a neurodegenerative disease of the eye where the correlation of biomarkers in circulating fluid may be made specific for the eye. However, conditions such as wet age-related macular degeneration (AMD) and proliferative diabetic retinopathy (DR), circulating biomarkers might be having some degree of overlap with other conditions like cancer where a common factor such as angiogenesis is involved. Diabetes, a systemic disorder affecting the target organs such as eye, kidney, heart, and nervous system can be predicted using common circulating biomarkers. However, these markers need to be validated along with various stages of disease progression to enable the possibility of targeted pharmacological interventions apart from good glycemic control alone. This review compiles the attempts made to correlate such circulating biomarkers in the ocular conditions such as glaucoma, AMD, and DR in the search for a surrogate marker for diagnostic and prognostic value. To make biomarkers for the common convenience, genetic markers are excluded from this review.
topic Age-related macular degeneration
circulating biomarkers in glaucoma
diabetic retinopathy
url http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=3;spage=191;epage=197;aulast=Nath
work_keys_str_mv AT madhunath circulatingbiomarkersinglaucomaagerelatedmaculardegenerationanddiabeticretinopathy
AT nabanitahalder circulatingbiomarkersinglaucomaagerelatedmaculardegenerationanddiabeticretinopathy
AT thirumurthyvelpandian circulatingbiomarkersinglaucomaagerelatedmaculardegenerationanddiabeticretinopathy
_version_ 1725609557059698688